Novo Nordisk A/S
NONOF
$122.50
-$0.306-0.25%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 10.86% | 8.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.86% | 8.11% | |||
| Cost of Revenue | 1.92% | 23.58% | |||
| Gross Profit | 12.63% | 5.49% | |||
| SG&A Expenses | 30.81% | -8.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 96.97% | -753.01% | |||
| Total Operating Expenses | 17.07% | 4.57% | |||
| Operating Income | 3.51% | 12.61% | |||
| Income Before Tax | -2.71% | 15.65% | |||
| Income Tax Expenses | 0.13% | 15.67% | |||
| Earnings from Continuing Operations | -3.41% | 15.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.41% | 15.64% | |||
| EBIT | 3.51% | 12.61% | |||
| EBITDA | -0.48% | 12.89% | |||
| EPS Basic | -3.15% | 15.99% | |||
| Normalized Basic EPS | 2.43% | 16.00% | |||
| EPS Diluted | -2.96% | 15.81% | |||
| Normalized Diluted EPS | 2.40% | 16.00% | |||
| Average Basic Shares Outstanding | -0.27% | -0.30% | |||
| Average Diluted Shares Outstanding | -0.26% | -0.30% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -1.00% | -- | |||
